A carregar...

National Trends in Hospitalizations for Sickle Cell Disease in the United States following the FDA Approval of Hydroxyurea, 1998 to 2008

BACKGROUND: Patients with sickle cell disease (SCD) can suffer frequent hospital admissions for painful vaso-occlusive crises. Hydroxyurea was approved by the FDA in 1998 to decrease the morbidity of SCD, but nationwide hospitalizations for SCD in the United States (US) since 1998 have not been eval...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Okam, Maureen M., Shaykevich, Shimon, Ebert, Benjamin L., Zaslavsky, Alan M., Ayanian, John Z.
Formato: Artigo
Idioma:Inglês
Publicado em: 2014
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4177169/
https://ncbi.nlm.nih.gov/pubmed/24926708
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MLR.0000000000000143
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!